9-环戊基腺嘌呤单甲磺酸盐
|
C334623-50mg
|
≥97% |
189639-09-6 |
50mg
|
¥ 7329.9
|
期货,请咨询 |
阿拉丁 |
9-环戊基腺嘌呤单甲磺酸盐
|
C334623-1mg
|
≥97% |
189639-09-6 |
1mg
|
¥ 859.9
|
期货,请咨询 |
阿拉丁 |
9-环戊基腺嘌呤单甲磺酸盐
|
C334623-10mg
|
≥97% |
189639-09-6 |
10mg
|
¥ 3159.9
|
期货,请咨询 |
阿拉丁 |
9-环戊基腺嘌呤单甲磺酸盐
|
C334623-100mg
|
≥97% |
189639-09-6 |
100mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
甲醇中胆固醇溶液标准物质
|
C302001-5ml
|
5.00μg/mL,U=5.0%,k=2 |
57-88-5 |
5ml
|
¥ 349.9
|
现货 |
阿拉丁 |
CW 008,PKA信号激活剂
|
C287829-25mg
|
≥98%(HPLC) |
1134613-19-6 |
25mg
|
¥ 3219.9
|
期货,请咨询 |
阿拉丁 |
CW 008,PKA信号激活剂
|
C287829-100mg
|
≥98%(HPLC) |
1134613-19-6 |
100mg
|
¥ 8999.9
|
期货,请咨询 |
阿拉丁 |
Calhex 231,钙敏感受体的负变构调节剂
|
C275037-50mg
|
Moligand™, ≥98% |
652973-93-8 |
50mg
|
¥ 6249.9
|
期货,请咨询 |
阿拉丁 |
Calhex 231,钙敏感受体的负变构调节剂
|
C275037-100mg
|
Moligand™, ≥98% |
652973-93-8 |
100mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
Cholesterol PEG NBD
|
C163448-5mg
|
MW 10000 Da |
N/A |
5mg
|
¥ 779.9
|
现货 |
阿拉丁 |
羰基咪唑-PEG-羰基咪唑
|
C163418-250mg
|
MW 3400 Da |
N/A |
250mg
|
¥ 359.9
|
现货 |
阿拉丁 |
碱性紫8
|
B405190-1g
|
|
8004-94-2 |
1g
|
¥ 69.9
|
现货 |
阿拉丁 |
3,6-双(5-溴-2-噻吩基)-2,5-双(2-己基癸基)-2,5-二氢-吡咯[3,4-c] 吡咯-1,4-二酮
|
B165329-50mg
|
≥98% |
1000623-98-2 |
50mg
|
¥ 75.9
|
现货 |
阿拉丁 |
碳酸锆铵
|
A742203-500g
|
Na≤50ppm,ZrO2 ≥20% in H2O,含HfO2 |
22829-17-0 |
500g
|
¥ 245.9
|
期货,请咨询 |
阿拉丁 |
碳酸锆铵
|
A742203-2.5kg
|
Na≤50ppm,ZrO2 ≥20% in H2O,含HfO2 |
22829-17-0 |
2.5kg
|
¥ 814.9
|
期货,请咨询 |
阿拉丁 |
腺苷3',5'-二磷酸二钠盐
|
A736749-5mg
|
≥95% |
75431-54-8 |
5mg
|
¥ 2599.9
|
期货,请咨询 |
阿拉丁 |
腺苷3',5'-二磷酸二钠盐
|
A736749-1mg
|
≥95% |
75431-54-8 |
1mg
|
¥ 699.9
|
现货 |
阿拉丁 |
腺苷3',5'-二磷酸二钠盐
|
A736749-10mg
|
≥95% |
75431-54-8 |
10mg
|
¥ 3999.9
|
期货,请咨询 |
阿拉丁 |
氰乙酸烯丙酯
|
A472840-5g
|
≥98% |
13361-32-5 |
5g
|
¥ 55.9
|
期货,请咨询 |
阿拉丁 |
氰乙酸烯丙酯
|
A472840-1g
|
≥98% |
13361-32-5 |
1g
|
¥ 29.9
|
现货 |
阿拉丁 |
氰乙酸烯丙酯
|
A472840-100g
|
≥98% |
13361-32-5 |
100g
|
¥ 775.9
|
现货 |
阿拉丁 |
19-醛雄烯二酮
|
A358875-5mg
|
≥95% |
968-49-0 |
5mg
|
¥ 599.9
|
现货 |
阿拉丁 |
19-醛雄烯二酮
|
A358875-25mg
|
≥95% |
968-49-0 |
25mg
|
¥ 1699.9
|
期货,请咨询 |
阿拉丁 |
酸性棕M
|
A353011-5g
|
≥90% |
5850-16-8 |
5g
|
¥ 75.9
|
现货 |
阿拉丁 |